[TIVA-TCI (Total IntraVenous Anesthesia-Target Controlled Infusion) versus isoflurane anesthesia for laparoscopic cholecystectomy. Postoperative nausea and vomiting, and patient satisfaction]. / TIVA-tCI vs. anestezia inhalatorie pentru colecistectomia laparoscopica. Incidenta sindromului emetic postoperator si satisfactia pacientilor.

UNLABELLED: Numerous studies have shown that TIVA is followed by a significant reduction in the incidence of PONV in day-case surgery, including laparoscopic cholecystectomy, where the incidence of PONV can reach 70% according to some studies. TCI is the TIVA technique that maintain a constant plasma concentration due to pharmacokynetic models incorporated in TCI device that inject the anesthetic agent. Besides implementing TIVA-TCI in clinical practice in Romania, our study was designed to evaluate the impact of TIVA-TCI on postoperative outcome and our patient satisfaction after laparoscopic cholecystectomy. PATIENTS AND METHODS: After informed consent, 70 patients ASAI/II undergoing laparoscopic cholecystectomy were randomized in 2 equal study groups: group 1 (n = 35) included patients with TIVA-TCI with propofol (Cpi = 4 microg/ml) and remifentanil, and group 2 (n = 35) were patients undergoing Isoflurane anesthesia. In both groups propofol was administered during induction and remifentanil followed the same protocol: 0.5 microg/kg/min in the first minute during induction, followed by 0.25 microg/kg/min. This infusion was modified by 0.05 microg/kg/min steps according to analgesic needs. PONV (evaluated as both incidence and number of episodes), severity of pain and patient satisfaction score IOWA were compared between study groups. RESULTS: Both the incidence of PONV (p = 0.03) and the number of episodes/24 h/patients (p = 0.01) were significantly lower in TIVA-TCI group, while there was no significant difference in opioid requirements in study groups (p = 0.21). Patients IOWA satisfaction score at 24 hours postoperatively was significantly higher in TIVA-TCI groups (p = 0.0001). CONCLUSIONS: Compared with Isoflurane, TIVA-TCI was followed by significantly lower incidence of PONV and significantly greater patients satisfaction.

[The sampling of pathological specimens for the diagnosis of infections in different clinical units]. / Recoltarea produselor patologice pentru diagnosticul infectiilor din diverse unitati clinice.

The probes sampled from patients, in hospital environment, sterility control departments, air microflora, medical personnel, were tested for the global number of germs and for the positivity registered. Between 1983 and 1994, 12,785 samples for microbiological examination were sampled, aiming to give emphasis to the nosocomial from units like: internal medicine and cardiology; surgery and intensive care; neonatology and pediatrics; obstetrics and gynecology. 7,430 samples were microbiologically positive, proving the potential circulation of facultatively aerobic and aerobic-anaerobic bacterial populations. Our investigations aimed to know more about the microbial structure inside the chosen medical units. The positivity of the samples differed widely from one unit to another, and was partially influenced by the number of the accomplished investigations. The selection of the different medical services was governed by the idea of knowing that the hospitalised patients have a much higher risk of exposure to nosocomial infections, than the patients from other medical services with beds.

New evolution in mitral physiology and surgery: mitral stentless pericardial valve.

The human adult mitral valve, with a mean diastolic area of up to 7.6 cm2, excess leaflet surface area for coaptation in systole, mitral annulus-papillary muscle continuity, and systolic constriction of the posterior left ventricular wall around the mitral annulus functions in concert with other components of the left side of the heart. Mitral valve replacement with an artificial valve that interferes with the normal physiology could account for less than adequate late results. A stentless biologic mitral valve substitute has been designed, constructed, and tested. The size of the valve is selected according to the circumference of the excised valve within certain limits. The valve is manufactured of two square or trapezoidal pieces of selected stabilized human autologous or bovine pericardium. The pericardial pieces are sutured together by their lateral margins, thus creating a frusto-conical valvular body. The upper circumference of the valvular body is sutured at the mitral annulus and the lower margin with the new chordae is attached by suture at each papillary muscle. In vitro testing of six stentless bovine pericardial valves in a Rowan-Ash fatigue tester at 1,200 cycles/min revealed a durability of more than 320 million cycles. Clinical use of described technique initiated in 1989 was performed in 18 patients by one surgeon (30 patients in the same institution). The mean valve size was 29 mm circularized diameter. There was no mortality in this group of patients up to 70 months of follow-up. Valve competence was obtained in every case by adequate sizing of the valve.(ABSTRACT TRUNCATED AT 250 WORDS)

[Improvement of the conditions of rat liver preservation by concomitant perfusion of the liver and kidney]. / Ameliorarea conditiilor de conservare a ficatului de sobolan prin perfuzie concomitenta cu rinichiul.

One of the factors limiting the duration of rat liver storage is the excessive accumulation of catabolites in the perfusion medium. In view of obtaining of an efficient depuration the authors have introduced a new circuit allowing for the concomittant perfusion of the liver and of the kidneys. The excretion effort of the kidneys is assessed by the estimation of urea nitrogen in the perfusion medium and in the urine collected over the entire duration of the experiment. The results have confirmed the good function of the system which provides possibilities for improved storage conditions of rat liver.